CER-522

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCER-522
Drug Alias NameCER-522
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionApolipoprotein A-I stimulants
TargetsApolipoprotein A-I
Therapy Area/IndicationsAortic Valve Stenosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCerenis Therapeutics Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCerenis Therapeutics Sa
Active IndicationsN/A
Inactive IndicationsAortic Valve Stenosis

Other Information

ATC CodeN/A
Related LinksN/A